CDC Tells States How to Prepare for COVID-19 Vaccine by Early November
The CDC has outlined technical scenarios to state public health officials for an unidentified Vaccine A and Vaccine B.
Read more at The New York Times
WHO Says Widespread Coronavirus Vaccinations Are Not Expected Until Mid-2021
None of the candidate vaccines in advanced clinical trials so far has demonstrated a “clear signal” of efficacy at the level of 50 percent sought by WHO.
Read more from CNBC
Reopening Reality: What to Do When an Employee is Exposed to COVID-19
The Families First Coronavirus Relief Act requires businesses to pay employees time off to quarantine and seek medical relief.
Read more from Remodeling
New COVID-19 Workplace Education Program Uses Interactive Training
The Association for Professionals in Infection Control and Epidemiology and Direct Education Worldwide have launched COVID SMART, which teaches and tests knowledge of the virus and basic infection prevention measures.
Read more at EHS Today
FDA Announces Emergency Authorization for Convalescent Plasma to Treat COVID-19
The U.S. FDA says the “known and potential benefits of the product outweigh the known and potential risks of the product.”
Read more at CNN
CDC Removes 14-Day Quarantine Recommendation
The Centers for Disease Control and Prevention (CDC) updated its travel requirements, advising travelers to “follow state, territorial, tribal and local recommendations or requirements after travel.”
Read more at USA Today
Latest on the Main Street Lending Program
The Congressional Oversight Commission authorized to review the CARES Act programs issued its fourth report on August 21. The panel conducted an oversight hearing on the Main Street Lending Program (MSLP) on August 7 with Boston Fed President and CEO – the officer in charge of the MSLP – as a key witness. The Commissioners were uniformly critical of the program and its slow implementation, and those criticisms are clearly reflected in their August 21 report.
Read more from NAW
Common Medication for Older Adults Improves COVID-19 Survival Rates, Researchers Say
Medication for high blood pressure could improve survival rates for those suffering from COVID-19 and reduce the severity of infection, according to new research from a team of scientists at the University of East Anglie in the U.K.
Read more at Market Watch
COVID-19 Treatments: What’s Taking the Clinical Trials So Long?
The clinical trials necessary have been fraught with delays and have had problems recruiting volunteers.
Read more at NBC News
Employees Want Contact Tracing Notification
A recent survey shows 86 percent of employees say an employer has an obligation to notify employees if they may have been in contact with a co-worker who has tested positive for COVID-19.
Read more at EHS Today
